Toggle Sidebar
Home
AI Agent
Annotations
Files
Pricing and plans
Help
Blog
About
Contact us
API
MCP
Terms of service
Privacy policy
Get the full experience
We save the real magic for signed-in users.
Sign In
ASMB US
Home
Stock Screener
Document Search
Charting
Watchlists
Recent Filings
Assembly Biosciences, Inc.
(ASMB US)
$21.12
+0.94
4.66%
Ext:
$20.99
-0.13
0.63%
(Market Closed · 00:47:50 UTC)
Ask AI
Follow
Doc Search
Profile
Entity Structure
SEC Filings
Financials
Charting
Short Interest
Employees
Toggle Sidebar
Home
AI Agent
Annotations
Files
Pricing and plans
Help
Blog
About
Contact us
API
MCP
Terms of service
Privacy policy
Get the full experience
We save the real magic for signed-in users.
Sign In
ASMB US
Home
Stock Screener
Document Search
Charting
Watchlists
Recent Filings
Assembly Biosciences, Inc.
(ASMB US)
$21.12
+0.94
4.66%
Ext:
$20.99
-0.13
0.63%
(Market Closed · 00:47:50 UTC)
Ask AI
Follow
Doc Search
Profile
Entity Structure
SEC Filings
Financials
Charting
Short Interest
Employees
Chronological
By Owner
Financials & Metrics
Financials
Charting
Short Interest
Employees
Chronological
By Owner
Financials & Metrics
Financials
Charting
Short Interest
Employees
SEC Filings
SEC Filings
Select Filings
Financials
(69)
Expand
10-Q
Q2
ended 30 Jun 2026
13 Aug
10-Q
Q1
ended 31 Mar 2026
7 May
10-K
FY 2025
ended 31 Dec 2025
19 Mar
10-Q
Q3
ended 30 Sept 2025
10 Nov 2025
10-Q
Q2
ended 30 Jun 2025
6 Aug 2025
10-Q
Q1
ended 31 Mar 2025
8 May 2025
10-K
FY 2024
ended 31 Dec 2024
20 Mar 2025
10-Q
Q3
ended 30 Sept 2024
7 Nov 2024
10-Q
Q2
ended 30 Jun 2024
8 Aug 2024
10-Q
Q1
ended 31 Mar 2024
8 May 2024
10-K
FY 2023
ended 31 Dec 2023
28 Mar 2024
10-Q
Q3
ended 30 Sept 2023
8 Nov 2023
10-Q
Q2
ended 30 Jun 2023
9 Aug 2023
10-Q
Q1
ended 31 Mar 2023
4 May 2023
10-K
FY 2022
ended 31 Dec 2022
22 Mar 2023
Events
(192)
Expand
8-K
Results of Operations and Financial Condition
12 Nov
8-K/A
Results of Operations and Financial Condition
14 Aug
8-K
Completion of Acquisition or Disposition of Assets
13 Aug
8-K
Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers
5 Jun
8-K
Entry into a Material Definitive Agreement
26 May
8-K
Regulation FD Disclosure
22 May
8-K
Results of Operations and Financial Condition
7 May
8-K
Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers
30 Mar
8-K
Results of Operations and Financial Condition
19 Mar
8-K
Regulation FD Disclosure
8 Dec 2025
8-K
Results of Operations and Financial Condition
10 Nov 2025
8-K
Entry into Material Agreement
11 Aug 2025
8-K
Assembly Biosciences Reports Positive Interim Results from Phase 1b Clinical Study of Long-Acting Helicase-Primase Inhibitor CandidateABI-5366Showing Reductions in Viral Shedding Rate and Genital Lesion Rate in Recurrent Genital Herpes
8 Aug 2025
8-K
Results of Operations and Financial Condition
6 Aug 2025
8-K
Other Events
25 Jun 2025
Insider Ownership
(337)
Expand
Form 4
Bjorkquist Jeanette M
3 Nov
Form 4
White Nicole S
3 Nov
Form 4
Delaney William E IV
3 Nov
Form 4
Gaggar Anuj
3 Nov
Form 4
Okazaki Jason A
3 Nov
Form 4
Bjorkquist Jeanette M
18 Jun
Form 4
Gaggar Anuj
5 Jun
Form 4
White Nicole S
5 Jun
Form 4
McHutchison John G
5 Jun
Form 4
Mahony Susan
5 Jun
Form 4
Johnson-Pratt Lisa
5 Jun
Form 4
Houghton Michael
5 Jun
Form 4
Consylman Gina
5 Jun
Form 4
ALTIG ANTHONY E
5 Jun
Form 4
Bjorkquist Jeanette M
5 Jun
Beneficial Ownership
(120)
Expand
SC 13G/A
ASSEMBLY BIOSCIENCES, INC.
14 Aug
SC 13G/A
ASSEMBLY BIOSCIENCES, INC.
13 Aug
SC 13G/A
ASSEMBLY BIOSCIENCES, INC.
4 Aug
SC 13D/A
ASSEMBLY BIOSCIENCES, INC.
27 May
SC 13G
ASSEMBLY BIOSCIENCES, INC.
11 May
SC 13G/A
ASSEMBLY BIOSCIENCES, INC.
9 Feb
SC 13G
ASSEMBLY BIOSCIENCES, INC.
8 Dec 2025
SC 13G
ASSEMBLY BIOSCIENCES, INC.
18 Aug 2025
SC 13G/A
ASSEMBLY BIOSCIENCES, INC.
18 Aug 2025
SC 13G
ASSEMBLY BIOSCIENCES, INC.
15 Aug 2025
SC 13G
ASSEMBLY BIOSCIENCES, INC.
15 Aug 2025
SC 13D/A
ASSEMBLY BIOSCIENCES, INC.
12 Aug 2025
SC 13G
ASSEMBLY BIOSCIENCES, INC.
12 Aug 2025
SC 13G/A
ASSEMBLY BIOSCIENCES, INC.
14 Feb 2025
SC 13G
ASSEMBLY BIOSCIENCES, INC.
23 Dec 2024
Other Ownership
(11)
Expand
Form 144
White Nicole S
2 Nov
Form 144
Gaggar Anuj
2 Nov
Form 144
Okazaki Jason A
2 Nov
Form 144
Delaney William E IV
3 Oct 2023
Form 144
Okazaki Jason A
3 Oct 2023
Form 144
Delaney William E IV
2 Aug 2023
Form 144
Okazaki Jason A
2 Aug 2023
Form 144
Delaney William E IV
30 May 2023
Form 144
Okazaki Jason A
23 May 2023
Form 144
McHutchison John G
23 May 2023
Form 144
Delaney William E IV
23 May 2023
Proxies
(47)
Expand
DEFA14A
Definitive additional materials
22 Apr
DEF 14A
Definitive proxy statement
22 Apr
ARS
Annual report to security holders
22 Apr
DEF 14A
Definitive proxy statement
23 Apr 2025
DEFA14A
Definitive additional materials
23 Apr 2025
ARS
Annual report to security holders
23 Apr 2025
DEF 14A
Definitive proxy statement
17 Apr 2024
ARS
Annual report to security holders
17 Apr 2024
DEFA14A
Definitive additional materials
17 Apr 2024
DEFA14A
Definitive additional materials
21 Dec 2023
DEF 14A
Definitive proxy statement
21 Dec 2023
PRE 14A
Preliminary proxy statement
11 Dec 2023
DEF 14A
Definitive proxy statement
12 Apr 2023
DEFA14A
Definitive additional materials
12 Apr 2023
ARS
Annual report to security holders
12 Apr 2023
Registrations
(77)
Expand
S-8
Registration statement (employee benefit plan)
20 Aug
424B5
Prospectus filing (Rule 424(b)(5))
22 May
424B5
Prospectus filing (Rule 424(b)(5))
22 May
S-3
Registration statement (primary offering)
19 Mar
S-8
Registration statement (employee benefit plan)
19 Mar
424B3
Prospectus filing (Rule 424(b)(3))
21 Nov 2025
S-3
Registration statement (primary offering)
14 Oct 2025
424B5
Prospectus filing (Rule 424(b)(5))
11 Aug 2025
424B5
Prospectus filing (Rule 424(b)(5))
11 Aug 2025
S-3MEF
Registration statement (additional securities, S-3)
7 Aug 2025
S-8
Registration statement (employee benefit plan)
6 Aug 2025
S-3
Registration statement (primary offering)
20 Mar 2025
424B5
Prospectus filing (Rule 424(b)(5))
7 Nov 2024
S-8
Registration statement (employee benefit plan)
8 Aug 2024
424B5
Prospectus filing (Rule 424(b)(5))
18 Jun 2024
Filing Review Correspondence
(15)
Expand
CORRESP
Filing review correspondence
25 Mar
CORRESP
Filing review correspondence
19 Nov 2025
CORRESP
Filing review correspondence
28 Mar 2025
CORRESP
Filing review correspondence
12 Apr 2023
CORRESP
Filing review correspondence
12 Jan 2021
CORRESP
Filing review correspondence
3 Sep 2020
CORRESP
Filing review correspondence
8 Jan 2018
CORRESP
Filing review correspondence
13 Jan 2016
CORRESP
Filing review correspondence
14 Jan 2015
CORRESP
Filing review correspondence
14 Dec 2010
UPLOAD
Filing review upload
8 Dec 2010
UPLOAD
Filing review upload
22 Nov 2010
UPLOAD
Filing review upload
8 Nov 2010
UPLOAD
Filing review upload
19 Oct 2010
UPLOAD
Filing review upload
16 Aug 2010
SEC Orders And Notices
(17)
Expand
EFFECT
Notice of effectiveness
30 Mar
EFFECT
Notice of effectiveness
24 Nov 2025
EFFECT
Notice of effectiveness
1 Apr 2025
EFFECT
Notice of effectiveness
14 Apr 2023
EFFECT
Notice of effectiveness
4 Sep 2020
EFFECT
Notice of effectiveness
10 Jan 2018
CT ORDER
Confidential treatment order
9 Jun 2017
EFFECT
Notice of effectiveness
19 Jan 2016
EFFECT
Notice of effectiveness
15 Jan 2015
CT ORDER
Confidential treatment order
13 Jan 2015
CT ORDER
Confidential treatment order
23 Jun 2014
CT ORDER
Confidential treatment order
18 Jul 2013
EFFECT
Notice of effectiveness
29 May 2012
EFFECT
Notice of effectiveness
10 Feb 2012
EFFECT
Notice of effectiveness
13 Jul 2011
Exempt Offerings
(3)
Expand
D
Notice of exempt offering of securities (Reg D)
24 May 2010
D/A
Notice of exempt offering of securities (Reg D, amendment)
26 Apr 2010
D
Notice of exempt offering of securities (Reg D)
12 Mar 2010
Other
(3)
Expand
SEC STAFF LETTER
SEC STAFF LETTER
26 Feb 2020
SEC STAFF LETTER
SEC STAFF LETTER
11 Feb 2020
CERTNAS
AUTO-GENERATED PAPER DOCUMENT
15 Dec 2010
Select Filings
Financials
(69)
Expand
10-Q
Q2
ended 30 Jun 2026
13 Aug
10-Q
Q1
ended 31 Mar 2026
7 May
10-K
FY 2025
ended 31 Dec 2025
19 Mar
10-Q
Q3
ended 30 Sept 2025
10 Nov 2025
10-Q
Q2
ended 30 Jun 2025
6 Aug 2025
10-Q
Q1
ended 31 Mar 2025
8 May 2025
10-K
FY 2024
ended 31 Dec 2024
20 Mar 2025
10-Q
Q3
ended 30 Sept 2024
7 Nov 2024
10-Q
Q2
ended 30 Jun 2024
8 Aug 2024
10-Q
Q1
ended 31 Mar 2024
8 May 2024
10-K
FY 2023
ended 31 Dec 2023
28 Mar 2024
10-Q
Q3
ended 30 Sept 2023
8 Nov 2023
10-Q
Q2
ended 30 Jun 2023
9 Aug 2023
10-Q
Q1
ended 31 Mar 2023
4 May 2023
10-K
FY 2022
ended 31 Dec 2022
22 Mar 2023
Events
(192)
Expand
8-K
Results of Operations and Financial Condition
12 Nov
8-K/A
Results of Operations and Financial Condition
14 Aug
8-K
Completion of Acquisition or Disposition of Assets
13 Aug
8-K
Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers
5 Jun
8-K
Entry into a Material Definitive Agreement
26 May
8-K
Regulation FD Disclosure
22 May
8-K
Results of Operations and Financial Condition
7 May
8-K
Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers
30 Mar
8-K
Results of Operations and Financial Condition
19 Mar
8-K
Regulation FD Disclosure
8 Dec 2025
8-K
Results of Operations and Financial Condition
10 Nov 2025
8-K
Entry into Material Agreement
11 Aug 2025
8-K
Assembly Biosciences Reports Positive Interim Results from Phase 1b Clinical Study of Long-Acting Helicase-Primase Inhibitor CandidateABI-5366Showing Reductions in Viral Shedding Rate and Genital Lesion Rate in Recurrent Genital Herpes
8 Aug 2025
8-K
Results of Operations and Financial Condition
6 Aug 2025
8-K
Other Events
25 Jun 2025
Insider Ownership
(337)
Expand
Form 4
Bjorkquist Jeanette M
3 Nov
Form 4
White Nicole S
3 Nov
Form 4
Delaney William E IV
3 Nov
Form 4
Gaggar Anuj
3 Nov
Form 4
Okazaki Jason A
3 Nov
Form 4
Bjorkquist Jeanette M
18 Jun
Form 4
Gaggar Anuj
5 Jun
Form 4
White Nicole S
5 Jun
Form 4
McHutchison John G
5 Jun
Form 4
Mahony Susan
5 Jun
Form 4
Johnson-Pratt Lisa
5 Jun
Form 4
Houghton Michael
5 Jun
Form 4
Consylman Gina
5 Jun
Form 4
ALTIG ANTHONY E
5 Jun
Form 4
Bjorkquist Jeanette M
5 Jun
Beneficial Ownership
(120)
Expand
SC 13G/A
ASSEMBLY BIOSCIENCES, INC.
14 Aug
SC 13G/A
ASSEMBLY BIOSCIENCES, INC.
13 Aug
SC 13G/A
ASSEMBLY BIOSCIENCES, INC.
4 Aug
SC 13D/A
ASSEMBLY BIOSCIENCES, INC.
27 May
SC 13G
ASSEMBLY BIOSCIENCES, INC.
11 May
SC 13G/A
ASSEMBLY BIOSCIENCES, INC.
9 Feb
SC 13G
ASSEMBLY BIOSCIENCES, INC.
8 Dec 2025
SC 13G
ASSEMBLY BIOSCIENCES, INC.
18 Aug 2025
SC 13G/A
ASSEMBLY BIOSCIENCES, INC.
18 Aug 2025
SC 13G
ASSEMBLY BIOSCIENCES, INC.
15 Aug 2025
SC 13G
ASSEMBLY BIOSCIENCES, INC.
15 Aug 2025
SC 13D/A
ASSEMBLY BIOSCIENCES, INC.
12 Aug 2025
SC 13G
ASSEMBLY BIOSCIENCES, INC.
12 Aug 2025
SC 13G/A
ASSEMBLY BIOSCIENCES, INC.
14 Feb 2025
SC 13G
ASSEMBLY BIOSCIENCES, INC.
23 Dec 2024
Other Ownership
(11)
Expand
Form 144
White Nicole S
2 Nov
Form 144
Gaggar Anuj
2 Nov
Form 144
Okazaki Jason A
2 Nov
Form 144
Delaney William E IV
3 Oct 2023
Form 144
Okazaki Jason A
3 Oct 2023
Form 144
Delaney William E IV
2 Aug 2023
Form 144
Okazaki Jason A
2 Aug 2023
Form 144
Delaney William E IV
30 May 2023
Form 144
Okazaki Jason A
23 May 2023
Form 144
McHutchison John G
23 May 2023
Form 144
Delaney William E IV
23 May 2023
Proxies
(47)
Expand
DEFA14A
Definitive additional materials
22 Apr
DEF 14A
Definitive proxy statement
22 Apr
ARS
Annual report to security holders
22 Apr
DEF 14A
Definitive proxy statement
23 Apr 2025
DEFA14A
Definitive additional materials
23 Apr 2025
ARS
Annual report to security holders
23 Apr 2025
DEF 14A
Definitive proxy statement
17 Apr 2024
ARS
Annual report to security holders
17 Apr 2024
DEFA14A
Definitive additional materials
17 Apr 2024
DEFA14A
Definitive additional materials
21 Dec 2023
DEF 14A
Definitive proxy statement
21 Dec 2023
PRE 14A
Preliminary proxy statement
11 Dec 2023
DEF 14A
Definitive proxy statement
12 Apr 2023
DEFA14A
Definitive additional materials
12 Apr 2023
ARS
Annual report to security holders
12 Apr 2023
Registrations
(77)
Expand
S-8
Registration statement (employee benefit plan)
20 Aug
424B5
Prospectus filing (Rule 424(b)(5))
22 May
424B5
Prospectus filing (Rule 424(b)(5))
22 May
S-3
Registration statement (primary offering)
19 Mar
S-8
Registration statement (employee benefit plan)
19 Mar
424B3
Prospectus filing (Rule 424(b)(3))
21 Nov 2025
S-3
Registration statement (primary offering)
14 Oct 2025
424B5
Prospectus filing (Rule 424(b)(5))
11 Aug 2025
424B5
Prospectus filing (Rule 424(b)(5))
11 Aug 2025
S-3MEF
Registration statement (additional securities, S-3)
7 Aug 2025
S-8
Registration statement (employee benefit plan)
6 Aug 2025
S-3
Registration statement (primary offering)
20 Mar 2025
424B5
Prospectus filing (Rule 424(b)(5))
7 Nov 2024
S-8
Registration statement (employee benefit plan)
8 Aug 2024
424B5
Prospectus filing (Rule 424(b)(5))
18 Jun 2024
Filing Review Correspondence
(15)
Expand
CORRESP
Filing review correspondence
25 Mar
CORRESP
Filing review correspondence
19 Nov 2025
CORRESP
Filing review correspondence
28 Mar 2025
CORRESP
Filing review correspondence
12 Apr 2023
CORRESP
Filing review correspondence
12 Jan 2021
CORRESP
Filing review correspondence
3 Sep 2020
CORRESP
Filing review correspondence
8 Jan 2018
CORRESP
Filing review correspondence
13 Jan 2016
CORRESP
Filing review correspondence
14 Jan 2015
CORRESP
Filing review correspondence
14 Dec 2010
UPLOAD
Filing review upload
8 Dec 2010
UPLOAD
Filing review upload
22 Nov 2010
UPLOAD
Filing review upload
8 Nov 2010
UPLOAD
Filing review upload
19 Oct 2010
UPLOAD
Filing review upload
16 Aug 2010
SEC Orders And Notices
(17)
Expand
EFFECT
Notice of effectiveness
30 Mar
EFFECT
Notice of effectiveness
24 Nov 2025
EFFECT
Notice of effectiveness
1 Apr 2025
EFFECT
Notice of effectiveness
14 Apr 2023
EFFECT
Notice of effectiveness
4 Sep 2020
EFFECT
Notice of effectiveness
10 Jan 2018
CT ORDER
Confidential treatment order
9 Jun 2017
EFFECT
Notice of effectiveness
19 Jan 2016
EFFECT
Notice of effectiveness
15 Jan 2015
CT ORDER
Confidential treatment order
13 Jan 2015
CT ORDER
Confidential treatment order
23 Jun 2014
CT ORDER
Confidential treatment order
18 Jul 2013
EFFECT
Notice of effectiveness
29 May 2012
EFFECT
Notice of effectiveness
10 Feb 2012
EFFECT
Notice of effectiveness
13 Jul 2011
Exempt Offerings
(3)
Expand
D
Notice of exempt offering of securities (Reg D)
24 May 2010
D/A
Notice of exempt offering of securities (Reg D, amendment)
26 Apr 2010
D
Notice of exempt offering of securities (Reg D)
12 Mar 2010
Other
(3)
Expand
SEC STAFF LETTER
SEC STAFF LETTER
26 Feb 2020
SEC STAFF LETTER
SEC STAFF LETTER
11 Feb 2020
CERTNAS
AUTO-GENERATED PAPER DOCUMENT
15 Dec 2010
Ask in Filing
Ask in Filing
